Performance analysis of Xenetic Biosciences (XBIO)
Annual Return
Over the past 3 years, XBIO has had an average annual return of -12.66%, underperforming the benchmark SPY, which returned +19.63% annual.
Over the past 5 years, XBIO has had an average annual return of -32.01%, underperforming the benchmark SPY, which returned +12.73% annual.
Over the past 10 years, XBIO has had an average annual return of -41.08%, underperforming the benchmark SPY, which returned +15.04% annual.
Since Apr 17, 2014, XBIO has had an average annual return of -44.08%, underperforming the benchmark SPY, which returned +13.90% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +33.33% | -50.00% | +20% | +25% | -78.95% | -37.70% | +41.86% | -92.65% | -14.47% | -55.38% | -74.45% | +104.01% |
| 2014 | |||||||||||
| -70.59% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +16.67% | +14.29% | +0% | +12.50% | +0% | +0% | -11.11% | +33.33% | |||||
| 2025 | +8.33% | -7.69% | -33.33% | +0% | +12.50% | +33.33% | -16.67% | -20.00% | +12.50% | +11.11% | -20.00% | -25.00% | -50.00% |
| 2024 | +10% | +9.09% | -8.33% | +18.18% | -7.69% | +0% | +8.33% | -7.69% | +8.33% | -7.69% | +8.33% | -7.69% | +20% |
| 2023 | +162.50% | -28.57% | -20.00% | -0% | -25.00% | +11.11% | +20% | +0% | +25% | -40.00% | +11.11% | +0% | +25% |
| 2022 | -21.05% | -6.67% | +7.14% | -26.67% | +9.09% | -0% | +12.50% | -14.81% | -30.43% | -12.50% | -7.14% | -38.46% | -78.95% |
| 2021 | +14.75% | +1.43% | -8.45% | -10.77% | -1.72% | +7.02% | +98.36% | -26.45% | -31.46% | -18.03% | -16.00% | -9.52% | -37.70% |
| 2020 | -2.33% | -30.95% | -24.14% | +22.73% | +11.11% | -0% | +16.67% | -11.43% | -12.90% | -3.70% | +30.77% | +79.41% | +41.86% |
| 2019 | +13.33% | +23.68% | -15.61% | -25.87% | -52.83% | +38.02% | -78.44% | -31.94% | -26.53% | -0% | +2.78% | +16.22% | -92.65% |
| 2018 | +8.92% | -6.71% | +10.22% | -16.71% | -12.85% | +161.69% | -27.70% | +0.67% | -4.72% | -13.48% | +34.71% | -50.26% | -14.47% |
| 2017 | +14.68% | -15.42% | +9.08% | +3.02% | -33.45% | -11.51% | +13.72% | -22.88% | -16.57% | +5.97% | -0.92% | -9.52% | -55.38% |
Drawdown analysis of Xenetic Biosciences (XBIO)
The maximum drawdown for the XBIO was -99.95%, occurring on Dec 16, 2025. This drawdown has not yet recovered.
The current XBIO drawdown is -99.93%.
Since Apr 17, 2014 XBIO has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 4 times
- 10% or more: 4 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.95% | Jul 11, 2014 | 2876 | Dec 16, 2025 | Ongoing | Ongoing | Ongoing |
| -68.09% | May 20, 2014 | 18 | Jun 16, 2014 | 5 | Jun 23, 2014 | 23 |
| -29.41% | Apr 17, 2014 | 21 | May 19, 2014 | 1 | May 20, 2014 | 22 |
| -25.14% | Jun 23, 2014 | 7 | Jul 2, 2014 | 6 | Jul 11, 2014 | 13 |